Clinical Trial Title
ALLIANCE “Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve” (Protocol Number 2021-05)National Clinical Trial Number:
NCT05172960Contact Information
Clinical Trial Protocol Description:
This study is to assess if the SAPIEN X4 Transcatheter Heart Valve (THV) is beneficial for people with symptomatic, severe, calcific aortic stenosis.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Are at least 18 years of age.
- Have severe, calcific aortic stenosis.
You will be excluded from the study if any of the following criteria apply to you:
- Have a pre-existing mechanical or bioprosthetic valve.
- Have an intracardiac mass, thrombus or vegetation evidenced through cardiac imaging.
- Have renal insufficiency.
- Have had a stroke within the past 90 days.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.
Study Details
Clinical Trial Investigator
Hussam Suradi, MD
Contact Information
Nusrat Jahan
Clinical Trial Location
RUSH University Medical Center